Navigation Links
Abbott's XIENCE V® Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
Date:9/23/2010

Abbott's XIENCE V® Shows Continue<br /><font style='display:none'>'/>"/></font></li></ul></table></ol></b></i></a><br /><table border=0 width=520><tr><td>SOURCE Abbott<br />Copyright©2010 <a href='http://www.prnewswire.com' target='_blank'>PR Newswire.</a><br />All rights reserved</td><td><div class="endSupport"><br /><font id="g_medicine_technology_11156">0</font><br /><br /><font class='good' id="c_medicine_technology_11156"><a href="javascript:hc('medicine_technology','11156')" target="_self">GOOD</a></font></div></td></tr></table><br /><center><b>Page: 1 <a href='/medicine-technology-1/Abbotts-XIENCE-V-AE-Shows-Continued-Strong-Performance-in-Key-Safety-and-Efficacy-Measures-at-Two-Years-in-Investigator-Initiated-COMPARE-Trial-11156-2/'>2</a> <a href='/medicine-technology-1/Abbotts-XIENCE-V-AE-Shows-Continued-Strong-Performance-in-Key-Safety-and-Efficacy-Measures-at-Two-Years-in-Investigator-Initiated-COMPARE-Trial-11156-3/'>3</a> <a href='/medicine-technology-1/Abbotts-XIENCE-V-AE-Shows-Continued-Strong-Performance-in-Key-Safety-and-Efficacy-Measures-at-Two-Years-in-Investigator-Initiated-COMPARE-Trial-11156-4/'>4</a> <a href='/medicine-technology-1/Abbotts-XIENCE-V-AE-Shows-Continued-Strong-Performance-in-Key-Safety-and-Efficacy-Measures-at-Two-Years-in-Investigator-Initiated-COMPARE-Trial-11156-5/'>5</a> <a href='/medicine-technology-1/Abbotts-XIENCE-V-AE-Shows-Continued-Strong-Performance-in-Key-Safety-and-Efficacy-Measures-at-Two-Years-in-Investigator-Initiated-COMPARE-Trial-11156-6/'>6</a> <a href='/medicine-technology-1/Abbotts-XIENCE-V-AE-Shows-Continued-Strong-Performance-in-Key-Safety-and-Efficacy-Measures-at-Two-Years-in-Investigator-Initiated-COMPARE-Trial-11156-7/'>7</a> <a href='/medicine-technology-1/Abbotts-XIENCE-V-AE-Shows-Continued-Strong-Performance-in-Key-Safety-and-Efficacy-Measures-at-Two-Years-in-Investigator-Initiated-COMPARE-Trial-11156-8/'>8</a> <a href='/medicine-technology-1/Abbotts-XIENCE-V-AE-Shows-Continued-Strong-Performance-in-Key-Safety-and-Efficacy-Measures-at-Two-Years-in-Investigator-Initiated-COMPARE-Trial-11156-9/'>9</a> </b></center><br /><font color=blue><b><i>Related medicine technology :</i></b></font><br /><br /><b>1</b>. <a href='/medicine-technology-1/Abbott-to-Present-Data-on-Market-Leading-XIENCE-V-AE-and-Promising-Vascular-Pipeline-at-TCT-2010-10925-1/'>Abbott to Present Data on Market-Leading XIENCE V® and Promising Vascular Pipeline at TCT 2010</a><br /><b>2</b>. <a href='/medicine-technology-1/New-Data-Reinforces-Safety-Profile-of-Abbotts-Market-Leading-XIENCE-V-28R-29-Drug-Eluting-Stent-9046-1/'>New Data Reinforces Safety Profile of Abbotts Market-Leading XIENCE V(R) Drug Eluting Stent</a><br /><b>3</b>. <a href='/medicine-technology-1/Abbotts-XIENCE-V-28R-29-Demonstrates-Significantly-Lower-Rates-of-MACE-and-Stent-Thrombosis-Compared-to-TAXUS-28R-29-Liberte-in-Investigator-Initiated-5042-1/'>Abbotts XIENCE V(R) Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS(R) Liberte in Investigator-Initiated COMPARE Trial</a><br /><b>4</b>. <a href='/medicine-technology-1/Abbotts-XIENCE-V-28R-29-Superior-to-TAXUS-28R-29-in-Key-Safety-and-Efficacy-Measures-in-SPIRIT-IV-Trial-5040-1/'>Abbotts XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial</a><br /><b>5</b>. <a href='/medicine-technology-1/Abbotts-XIENCE-V-28R-29-Continues-to-Outperform-TAXUS-With-Sustained-Clinical-Advantages-and-Impressive-Long-Term-Safety-Results-in-SPIRIT-III-Trial-5024-1/'>Abbotts XIENCE V(R) Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long-Term Safety Results in SPIRIT III Trial</a><br /><b>6</b>. <a href='/medicine-technology-1/Abbotts-Market-Leading-XIENCE-V-28R-29-Shows-Increasing-Clinical-Advantages-Over-TAXUS-28R-29-Express2-28TM-29-TAXUS-28R-29-Liberte-28TM-29-Between-Tw-4091-1/'>Abbotts Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years</a><br /><b>7</b>. <a href='/medicine-technology-1/Circulation-Publishes-Pivotal-Two-Year-Results-On-XIENCE-V-28TM-29-Drug-Eluting-Stent-3751-1/'>Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent</a><br /><b>8</b>. <a href='/medicine-technology-1/Abbotts-XIENCE-V-28TM-29-Drug-Eluting-Stent-Outperforms-TAXUS-28R-29-in-Key-Efficacy-and-Safety-Endpoints-Out-to-Two-Years-3279-1/'>Abbotts XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years</a><br /><b>9</b>. <a href='/medicine-technology-1/XIENCE-28TM-29-V-Drug-Eluting-Stent-from-Abbott-Outperforms-Market-Leading-Stent-in-Reducing-Major-Adverse-Cardiac-Events-at-Two-Years-2049-1/'>XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years</a><br /><b>10</b>. <a href='/medicine-technology-1/Study-in-JAMA-Shows-Patients-Treated-With-Abbotts-XIENCE-28TM-29-V-Drug-Eluting-Stent-Experience-Better-Outcomes-Than-Patients-Treated-With-Market-Lea-1874-1/'>Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent</a><br /><b>11</b>. <a href='/medicine-technology-1/Abbotts-XIENCE-28TM-29-V-Drug-Eluting-Stent-Demonstrates-Consistent-and-Positive-Clinical-Outcomes-Out-to-Two-Years-1639-1/'>Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years</a><br /> </div><script type="text/javascript"><!-- google_ad_client = "ca-pub-8391600731032049"; /* biomed 468x60 */ google_ad_slot = "6344210719"; google_ad_width = 468; google_ad_height = 60; //--> </script> <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> </script></div><div id='Comments'><span id='CommentsTopic'>Post Your Comments: <script>document.write("(<a href=# onclick=opcu('technology-1','medicine','11156','www.bio-medicine.org/medicine-technology-1/Abbotts-XIENCE-V-AE-Shows-Continued-Strong-Performance-in-Key-Safety-and-Efficacy-Measures-at-Two-Years-in-Investigator-Initiated-COMPARE-Trial-11156-1/','Abbott%27s%20XIENCE%20V%AE%20Shows%20Continued%20Strong%20Performance%20in%20Key%20Safety%20and%20Efficacy%20Measures%20at%20Two%20Years%20in%20Investigator-Initiated%20COMPARE%20Trial')><font color=#000000>View All Comments</font></a>)")</script></span><div id='CommentsNav'><form name='cfrm' method='post' action='http://www.bio-medicine.org/zjm_comments.asp'><table border=0 cellspacing=0 cellpadding=0><tr><td><table border=0 cellspacing=0 cellpadding=0><tr><td><span style='color:red'>*</span>Name:</td><td><input name='username' style='width:250px'></td></tr><tr><td><span style='color:red'>*</span>Comment:</td><td><TEXTAREA style='WIDTH: 250px; HEIGHT: 78px' name=comment rows='1' cols='20'></TEXTAREA> </td></tr><tr><td><span style='color:red'>*</span>Email:</td><td><input name='email' width='50' style='WIDTH: 250px;'></td></tr><input type=hidden name='index' value='medicine'><input type=hidden name='index1' value='technology-1'><input type=hidden name='index_id' value='11156'><tr><td></td><td><input type='submit' name='submit' value=' Submit '> <input type='reset' value=' Reset '></td></tr></form></table></td><td width=20></td><td width=200></td></tr></table></div></div></div><div id='rightColumn'><div id='dixsw9'><div id='zf10' class='y'>(Date:8/28/2014)... Calif. , Aug. 28, 2014  STAAR Surgical Company ... marketer of implantable lenses and delivery systems for the eye, ... Health Care Conference at the New York Palace Hotel on ... Barry Caldwell , President and CEO will offer ... results, and operational developments and be joined by Steve ... </div><div id='zf11' class='y'>(Date:8/27/2014)... 2014 TWi Pharmaceuticals, Inc. (4180.TT) today announced ... United States Food and Drug Administration (FDA) on ... acetate 125mg/ml oral suspension, the generic equivalent to ... and under Hatch Waxman rules, it will be ... has completed the pre-launch preparation of the generic ... </div><div id='zf12' class='y'>(Date:8/27/2014)... Va. , Aug. 27, 2014 About ... the legs due to buildup of fatty plaque in ... in the aging patient population and in incidences of ... offers its Lower Extremity Arterial RevascularizatioN (LEARN) ... Endovascular specialists and interested residents and fellows ... </div><span id='rightColTopic'><a href='/medicine-technology-1/'>Breaking Medicine Technology:</a><a id='sy' href='/medicine-technology-1/STAAR-Surgical-To-Present-At-The-Baird-2014-Health-Care-Conference-39581-2/'>STAAR Surgical To Present At The Baird 2014 Health Care Conference 2</a><a id='sy' href='/medicine-technology-1/TWi-Pharmaceuticals-Receives-US-FDA-Final-Approval-on-Generic-Megestrol-Acetate-125mg-ml-Oral-Suspension-39576-2/'>TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2</a><a id='sy' href='/medicine-technology-1/LEARN-to-Treat-Peripheral-Arterial-Disease-Patients-39571-2/'>LEARN to Treat Peripheral Arterial Disease Patients 2</a><a id='sy' href='/medicine-technology-1/LEARN-to-Treat-Peripheral-Arterial-Disease-Patients-39571-3/'>LEARN to Treat Peripheral Arterial Disease Patients 3</a></span><div id='linkslist1'><a href='/medicine-technology-1/STAAR-Surgical-To-Present-At-The-Baird-2014-Health-Care-Conference-39581-1/' onmousemove=t('f10') onmouseout=r('f10')>[<font color=blue><b>0</b></font>] STAAR Surgical To Present At The Baird 2014 Health Care Conference</a><a href='/medicine-technology-1/TWi-Pharmaceuticals-Receives-US-FDA-Final-Approval-on-Generic-Megestrol-Acetate-125mg-ml-Oral-Suspension-39576-1/' onmousemove=t('f11') onmouseout=r('f11')>[<font color=blue><b>0</b></font>] TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension</a><a href='/medicine-technology-1/LEARN-to-Treat-Peripheral-Arterial-Disease-Patients-39571-1/' onmousemove=t('f12') onmouseout=r('f12')>[<font color=blue><b>0</b></font>] LEARN to Treat Peripheral Arterial Disease Patients</a></div></div><div id='dixsw10'><div id='zf0' class='y'>... 11, 2010 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE Amex: ... leading fully-integrated specialty pharmaceuticals company in China, today announced financial ... ThirdQ uarter Highlights ... the third quarter of fiscal year 2009 Excluding an ...</div><div id='zf1' class='y'>... BOSTON, November 11, 2010 ... ... --> ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r ...</div><span id='rightColTopic'><a href='/medicine-technology-1/'>Cached Medicine Technology:</a><a id='sy' href='/medicine-technology-1/China-Pharma-Holdings--Inc--Reports-Third-Quarter-2010-Financial-Results-12695-2/'>China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 2</a><a id='sy' href='/medicine-technology-1/China-Pharma-Holdings--Inc--Reports-Third-Quarter-2010-Financial-Results-12695-3/'>China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 3</a><a id='sy' href='/medicine-technology-1/China-Pharma-Holdings--Inc--Reports-Third-Quarter-2010-Financial-Results-12695-4/'>China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 4</a><a id='sy' href='/medicine-technology-1/China-Pharma-Holdings--Inc--Reports-Third-Quarter-2010-Financial-Results-12695-5/'>China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 5</a><a id='sy' href='/medicine-technology-1/China-Pharma-Holdings--Inc--Reports-Third-Quarter-2010-Financial-Results-12695-6/'>China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 6</a><a id='sy' href='/medicine-technology-1/China-Pharma-Holdings--Inc--Reports-Third-Quarter-2010-Financial-Results-12695-7/'>China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 7</a><a id='sy' href='/medicine-technology-1/China-Pharma-Holdings--Inc--Reports-Third-Quarter-2010-Financial-Results-12695-8/'>China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 8</a><a id='sy' href='/medicine-technology-1/China-Pharma-Holdings--Inc--Reports-Third-Quarter-2010-Financial-Results-12695-9/'>China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 9</a><a id='sy' href='/medicine-technology-1/EvaluatePharma-USA--Inc--Welcomed-Into-Boston-Biotech-Community-by-Mayor-Menino-12693-2/'>EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 2</a><a id='sy' href='/medicine-technology-1/EvaluatePharma-USA--Inc--Welcomed-Into-Boston-Biotech-Community-by-Mayor-Menino-12693-3/'>EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 3</a><a id='sy' href='/medicine-technology-1/EvaluatePharma-USA--Inc--Welcomed-Into-Boston-Biotech-Community-by-Mayor-Menino-12693-4/'>EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 4</a><a id='sy' href='/medicine-technology-1/EvaluatePharma-USA--Inc--Welcomed-Into-Boston-Biotech-Community-by-Mayor-Menino-12693-5/'>EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 5</a><a id='sy' href='/medicine-technology-1/EvaluatePharma-USA--Inc--Welcomed-Into-Boston-Biotech-Community-by-Mayor-Menino-12693-6/'>EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 6</a><a id='sy' href='/medicine-technology-1/EvaluatePharma-USA--Inc--Welcomed-Into-Boston-Biotech-Community-by-Mayor-Menino-12693-7/'>EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 7</a><a id='sy' href='/medicine-technology-1/EvaluatePharma-USA--Inc--Welcomed-Into-Boston-Biotech-Community-by-Mayor-Menino-12693-8/'>EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 8</a></span><div id='linkslist1'><a href='/medicine-technology-1/China-Pharma-Holdings--Inc--Reports-Third-Quarter-2010-Financial-Results-12695-1/' onmousemove=t('f0') onmouseout=r('f0')>China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results</a><a href='/medicine-technology-1/EvaluatePharma-USA--Inc--Welcomed-Into-Boston-Biotech-Community-by-Mayor-Menino-12693-1/' onmousemove=t('f1') onmouseout=r('f1')>EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino</a></div></div><div id='dixsw2'><div id='zdd10' class='y'>(Date:8/28/2014)... researchers place glue directly on the nerve stumps, but ... and allows glue to easily invade the nerve ends. ... to insert the nerve ends into the conduit because ... Xiangdang Liang and co-workers from the General Hospital of ... technique and defined the best parameters for its use ... </div><div id='zdd11' class='y'>(Date:8/28/2014)... 2014 One in every 200 Ontarians has been ... of people living with the disease increasing by 64 ... study by researchers at the Institute for Clinical Evaluative ... and the Ottawa Hospital Research Institute. That puts Ontario ... world. , The study, published this week in ... </div><div id='zdd12' class='y'>(Date:8/28/2014)... BCC Research ( http://www.bccresearch.com ) reveals in ... GLOBAL MARKETS , the global market for surgical navigation ... by the need for replacement of existing installations and ... the market is expected to grow to $631.9 million ... from 2013 through 2018. , While revenue generation will ... </div><div id='zdd13' class='y'>(Date:8/28/2014)... Port Washington, New York (PRWEB) August 28, 2014 ... law firm that has spent many years fighting to ... comments that the decision to provide coverage to WTC ... report released by the U.S. Government Accountability Office (GAO). ... Watch on August 25th, the report is entitled ... </div><div id='zdd14' class='y'>(Date:8/28/2014)... Clarity PSO , an operating division ... federal Patient Safety Organization (PSO) for another three-year period ... and Quality (AHRQ). Clarity PSO will continue to provide ... the true intentions of the Patient Safety and Quality ... and eager to continue our journey as a PSO ... </div><span id='rightColTopic'><a href='/medicine-news-1/'>Breaking Medicine News(10 mins):</a><a id='sy' href='/medicine-news-1/Ontario-has-one-of-the-highest-rates-of-IBD-in-the-world-132664-2/'>Health News:Ontario has one of the highest rates of IBD in the world 2</a><a id='sy' href='/medicine-news-1/Global-Market-for-Surgical-Navigation-Systems-Expected-to-Reach--24631-9-Million-in-2018-3B-ENT-Systems-Segment-Leading-With-10-4-25-CAGR-132660-2/'>Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 2</a><a id='sy' href='/medicine-news-1/Global-Market-for-Surgical-Navigation-Systems-Expected-to-Reach--24631-9-Million-in-2018-3B-ENT-Systems-Segment-Leading-With-10-4-25-CAGR-132660-3/'>Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 3</a><a id='sy' href='/medicine-news-1/GAO-Report-Reaffirms-Decision-to-Add-Cancers-to-List-of-Illnesses-Covered-under-the-Zadroga-Act--Parker-Waichman-LLP-Comments-132656-2/'>Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 2</a><a id='sy' href='/medicine-news-1/GAO-Report-Reaffirms-Decision-to-Add-Cancers-to-List-of-Illnesses-Covered-under-the-Zadroga-Act--Parker-Waichman-LLP-Comments-132656-3/'>Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 3</a><a id='sy' href='/medicine-news-1/Clarity-PSO-Re-lists-as-a-Patient-Safety-Organization-and-Continues-to-Advance-Patient-Safety-132652-2/'>Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2</a><a id='sy' href='/medicine-news-1/Clarity-PSO-Re-lists-as-a-Patient-Safety-Organization-and-Continues-to-Advance-Patient-Safety-132652-3/'>Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3</a></span><div id='linkslist1'><a href='/medicine-news-1/Sciatic-nerve-repair-using-adhesive-bonding-and-a-modified-conduit-132668-1/' onmousemove=t('dd10') onmouseout=r('dd10')>[<font color=blue><b>0</b></font>] Sciatic nerve repair using adhesive bonding and a modified conduit</a><a href='/medicine-news-1/Ontario-has-one-of-the-highest-rates-of-IBD-in-the-world-132664-1/' onmousemove=t('dd11') onmouseout=r('dd11')>[<font color=blue><b>0</b></font>] Ontario has one of the highest rates of IBD in the world</a><a href='/medicine-news-1/Global-Market-for-Surgical-Navigation-Systems-Expected-to-Reach--24631-9-Million-in-2018-3B-ENT-Systems-Segment-Leading-With-10-4-25-CAGR-132660-1/' onmousemove=t('dd12') onmouseout=r('dd12')>[<font color=blue><b>0</b></font>] Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR</a><a href='/medicine-news-1/GAO-Report-Reaffirms-Decision-to-Add-Cancers-to-List-of-Illnesses-Covered-under-the-Zadroga-Act--Parker-Waichman-LLP-Comments-132656-1/' onmousemove=t('dd13') onmouseout=r('dd13')>[<font color=blue><b>0</b></font>] GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments</a><a href='/medicine-news-1/Clarity-PSO-Re-lists-as-a-Patient-Safety-Organization-and-Continues-to-Advance-Patient-Safety-132652-1/' onmousemove=t('dd14') onmouseout=r('dd14')>[<font color=blue><b>0</b></font>] Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety</a></div></div><div id='dixsw7'><div id='zd0' class='y'>... Therapeutics Inc. (Nasdaq: CRTX ), a specialty pharmaceutical company focused on ... today reported financial results for the three and six months ended June 30, ... , , Second quarter net revenues increase ... , , , ...</div><div id='zd1' class='y'>... , MARL, Germany, Aug. 11 Smith & ... SNN ) announced that the German District Court in Dusseldorf decided ... Kinetic Concepts, Inc (NYSE: KCI ) for a Preliminary ... Pressure Wound Therapy (NPWT) pump in Germany based on alleged infringement ...</div><div id='zd2' class='y'>... ... teeth whitening treatments , ... MN (PRWEB) August 11, 2009 -- Dr. Wilhelm , DMD MSD, announced today he ... Spraywhite , the only spray-on, in-home professional teeth whitening treatment. Made with Aerowhite™, WOW ...</div><div id='zd3' class='y'>... ... Healthcare, a Wake Forest, NC company specializing in retinal health assessment for diabetics. ... (PRWEB) August 11, ... Digital Healthcare, a Wake Forest, NC company specializing in retinal health assessment for diabetics. ...</div><div id='zd4' class='y'>... DALLAS Aug. 11, 2009 People diagnosed with type ... weight, developing low blood sugar and seeing their quality of ... Medical Center suggests that those fears are largely unfounded and ... defense, as opposed to a treatment of last resort for ...</div><div id='zd5' class='y'>... , , ... Obama,s efforts to position government-funded health care as a "cost-cutter" for ... to reduce health care costs, according to a national survey question ... The majority of respondents believe national tort reform laws ...</div><span id='rightColTopic'><a href='/medicine-news-1/'>Cached Medicine News:</a><a id='sy' href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-2/'>Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 2</a><a id='sy' href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-3/'>Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 3</a><a id='sy' href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-4/'>Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 4</a><a id='sy' href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-5/'>Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 5</a><a id='sy' href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-6/'>Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 6</a><a id='sy' href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-7/'>Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 7</a><a id='sy' href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-8/'>Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 8</a><a id='sy' href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-9/'>Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 9</a><a id='sy' href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-10/'>Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 10</a><a id='sy' href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-11/'>Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 11</a><a id='sy' href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-12/'>Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 12</a><a id='sy' href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-13/'>Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 13</a><a id='sy' href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-14/'>Health News:Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 14</a><a id='sy' href='/medicine-news-1/German-District-Court-Rules-in-Smith--26-Nephews-Favor-in-Patent-Infringement-Case-54146-2/'>Health News:German District Court Rules in Smith & Nephew's Favor in Patent Infringement Case 2</a><a id='sy' href='/medicine-news-1/German-District-Court-Rules-in-Smith--26-Nephews-Favor-in-Patent-Infringement-Case-54146-3/'>Health News:German District Court Rules in Smith & Nephew's Favor in Patent Infringement Case 3</a><a id='sy' href='/medicine-news-1/Dr--Wilhelm--First-Minnesota-Cosmetic-Dentist-to-Offer-WOW-Spraywhite-Teeth-Whitening--54142-2/'>Health News:Dr. Wilhelm, First Minnesota Cosmetic Dentist to Offer WOW Spraywhite Teeth Whitening 2</a><a id='sy' href='/medicine-news-1/Dr--Wilhelm--First-Minnesota-Cosmetic-Dentist-to-Offer-WOW-Spraywhite-Teeth-Whitening--54142-3/'>Health News:Dr. Wilhelm, First Minnesota Cosmetic Dentist to Offer WOW Spraywhite Teeth Whitening 3</a><a id='sy' href='/medicine-news-1/The-Jones-Center-for-Diabetes--26amp-3B-Endocrine-Wellness-Selects-Retasure-to-Enhance-Diabetes-Care-54138-2/'>Health News:The Jones Center for Diabetes & Endocrine Wellness Selects Retasure to Enhance Diabetes Care 2</a><a id='sy' href='/medicine-news-1/UT-Southwestern-physicians-bust-myths-about-insulin-54134-2/'>Health News:UT Southwestern physicians bust myths about insulin 2</a><a id='sy' href='/medicine-news-1/New-Poll-Shows-Two-Thirds-of-Americans-Dont-Think-Government-Health-Care-Will-Cut-Costs-54130-2/'>Health News:New Poll Shows Two-Thirds of Americans Don't Think Government Health Care Will Cut Costs 2</a></span><div id='linkslist1'><a href='/medicine-news-1/Cornerstone-Therapeutics-Reports-Second-Quarter-and-First-Half-2009-Financial-Results-54150-1/' onmousemove=t('d0') onmouseout=r('d0')>Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results</a><a href='/medicine-news-1/German-District-Court-Rules-in-Smith--26-Nephews-Favor-in-Patent-Infringement-Case-54146-1/' onmousemove=t('d1') onmouseout=r('d1')>German District Court Rules in Smith & Nephew's Favor in Patent Infringement Case</a><a href='/medicine-news-1/Dr--Wilhelm--First-Minnesota-Cosmetic-Dentist-to-Offer-WOW-Spraywhite-Teeth-Whitening--54142-1/' onmousemove=t('d2') onmouseout=r('d2')>Dr. Wilhelm, First Minnesota Cosmetic Dentist to Offer WOW Spraywhite Teeth Whitening </a><a href='/medicine-news-1/The-Jones-Center-for-Diabetes--26amp-3B-Endocrine-Wellness-Selects-Retasure-to-Enhance-Diabetes-Care-54138-1/' onmousemove=t('d3') onmouseout=r('d3')>The Jones Center for Diabetes & Endocrine Wellness Selects Retasure to Enhance Diabetes Care</a><a href='/medicine-news-1/UT-Southwestern-physicians-bust-myths-about-insulin-54134-1/' onmousemove=t('d4') onmouseout=r('d4')>UT Southwestern physicians bust myths about insulin</a><a href='/medicine-news-1/New-Poll-Shows-Two-Thirds-of-Americans-Dont-Think-Government-Health-Care-Will-Cut-Costs-54130-1/' onmousemove=t('d5') onmouseout=r('d5')>New Poll Shows Two-Thirds of Americans Don't Think Government Health Care Will Cut Costs</a></div></div><div id='dixsw8'><div id='ze0' class='y'>Designed for simple operation, the Model 515B pulse oximeter is ideal for use in any clinical setting; from emergency hospital transport to continuous monitoring in Anesthesia, Intensive Care and Gen...</div><div id='ze1' class='y'>... The Models 512 and 513 handheld ... This advanced technology is able to ... resolutions and speeds of 100 times ... in improved pulse oximeter performance during ...</div><div id='ze2' class='y'>... Whether it's for an emergency situation, bedside ... Handheld Capnograph / Pulse Oximeter delivers accurate ... This portable, handheld monitor now contains Nellcors ... compatible with OxiMax sensors. The NPB-75 monitor ...</div><div id='ze3' class='y'>The new Nellcor N-45 Handheld Pulse Oximeter is compatible with our complete line of OxiMax Pulse Oximetry Sensors, so clinicians have the convenience of Nellcors most advanced sensor technology in a...</div><span id='rightColTopic'><a href='/medicine-products/'>Medicine Products:</a></span><div id='linkslist1'><a href='/medicine-products/Model-515B-Pulse-Oximeter-15804-1/' onmousemove=t('e0') onmouseout=r('e0')>Model 515B Pulse Oximeter</a><a href='/medicine-products/Model-513-Handheld-Pulse-Oximeter-15802-1/' onmousemove=t('e1') onmouseout=r('e1')>Model 513 Handheld Pulse Oximeter</a><a href='/medicine-products/OxiMax-26reg-3B-NPB-75-Handheld-Capnograph-Pulse-Oximeter-15800-1/' onmousemove=t('e2') onmouseout=r('e2')>OxiMax® NPB-75 Handheld Capnograph/Pulse Oximeter</a><a href='/medicine-products/N-45-Handheld-Pulse-Oximeter-15798-1/' onmousemove=t('e3') onmouseout=r('e3')>N-45 Handheld Pulse Oximeter</a></div></div><div id='edli' style='display:none;'><span id='leftColTopic'>Biology Navigation</span><div id='leftax'><ul id='leftall'><li><a href='/biology.asp?s=AIDS/HIV&w=AIDS-HIV'>AIDS/HIV</a></li><li><a href='/biology.asp?s=Bioinformatics&w=Bioinformatics'>Bioinformatics</a></li><li><a href='/biology.asp?s=Biotechnology&w=Biotech'>Biotechnology</a></li><li><a href='/biology.asp?s=Biochemistry&w=chemis'>Biochemistry</a></li><li><a href='/biology.asp?s=Cancer&w=Cancer'>Cancer</a></li><li><a href='/biology.asp?w=Cell%20&s=Cell%20Biology'>Cell Biology</a></li><li><a href='/biology.asp?s=Developmental%20Biology&w=Developme'>Developmental Biology</a></li><li><a href='/biology.asp?s=Ecology&w=Ecology'>Ecology</a></li><li><a href='/biology.asp?s=Environment&w=Environment'>Environment</a></li><li><a href='/biology.asp?s=Evolution&w=Evolution'>Evolution</a></li><li><a href='/biology.asp?w=%20Food%20&s=Food%20Technology'>Food Technology</a></li><li><a href='/biology.asp?s=Gene&w=Gene'>Gene</a></li><li><a href='/biology.asp?s=Genetics&w=Genetic'>Genetics</a></li><li><a href='/biology.asp?s=Genomics&w=Genomic'>Genomics</a></li><li><a href='/biology.asp?s=Health/Medicine&w=Health-Medicine-medical'>Health/Medicine</a></li><li><a href='/biology.asp?s=Immunology&w=Immun'>Immunology</a></li><li><a href='/biology.asp?s=Microarray&w=Microarray'>Microarray</a></li><li><a href='/biology.asp?s=Microbiology&w=Microbiology'>Microbiology</a></li><li><a href='/biology.asp?s=Molecular&w=Molecular'>Molecular</a></li><li><a href='/biology.asp?s=Marine%20Biology&w=Marine'>Marine Biology</a></li><li><a href='/biology.asp?s=Nanobiotechnology&w=Nano'>Nanobiotechnology</a></li><li><a href='/biology.asp?s=Neurobiology&w=Neuro'>Neurobiology</a></li><li><a href='/biology.asp?s=Plant%20Sciences&w=Plant'>Plant Sciences</a></li><li><a href='/biology.asp?s=Stem%20Cell&w=Stem%20Cell'>Stem Cell</a></li><li><a href='/biology.asp?s=Systems%20Biology&w=System'>Systems Biology</a></li><li><a href='/biology.asp?s=Virus&w=Virus'>Virus</a></li><li><a href='/biology.asp?s=Women%20Health&w=Women'>Women Health</a></li></ul></div><span id='leftColTopic'>Medical Navigation</span><div id='leftax'><ul id='leftall'><li><a href='/medicine.asp?s=Abortion&w=Abortion'>Abortion</a></li><li><a href='/medicine.asp?s=Aches&w=Ache'>Aches</a></li><li><a href='/medicine.asp?s=ADHD&w=ADHD'>ADHD</a></li><li><a href='/medicine.asp?s=Addiction&w=Addiction'>Addiction</a></li><li><a href='/medicine.asp?s=Alcohol&w=Alcohol'>Alcohol</a></li><li><a href='/medicine.asp?s=Allergy&w=Allergy'>Allergy</a></li><li><a href='/medicine.asp?s=Alternative%20Medicine&w=Alternative'>Alternative Medicine</a></li><li><a href='/medicine.asp?s=Alzheimer%27s%20Dementia&w=Alzheimer'>Alzheimer's Dementia</a></li><li><a href='/medicine.asp?s=Anxiety/Stress&w=Anxiety-Stress'>Anxiety/Stress</a></li><li><a href='/medicine.asp?s=Arthritis&w=Arthritis'>Arthritis</a></li><li><a href='/medicine.asp?s=Autism&w=Autism'>Autism</a></li><li><a href='/medicine.asp?s=Bacteria&w=Bacteria'>Bacteria</a></li><li><a href='/medicine.asp?s=Blood&w=Blood'>Blood</a></li><li><a href='/medicine.asp?s=Bird%20Flu/Avian%20Flu&w=Bird%20Flu-Avian%20Flu'>Bird Flu/Avian Flu</a></li><li><a href='/medicine.asp?s=Bones&w=Bone'>Bones</a></li><li><a href='/medicine.asp?s=Breast%20Cancer&w=Breast%20Cancer'>Breast Cancer</a></li><li><a href='/medicine.asp?s=Cancer&w=Cancer'>Cancer</a></li><li><a href='/medicine.asp?s=Cardiovascular&w=Cardiovascular'>Cardiovascular</a></li><li><a href='/medicine.asp?s=Cervical%20Cancer&w=Cervical%20Cancer'>Cervical Cancer</a></li><li><a href='/medicine.asp?s=Chikungunya&w=Chikungunya'>Chikungunya</a></li><li><a href='/medicine.asp?s=Cholesterol&w=Cholesterol'>Cholesterol</a></li><li><a href='/medicine.asp?s=Clinical%20Trials&w=Clinical'>Clinical Trials</a></li><li><a href='/medicine.asp?s=Colorectal%20Cancer&w=Colorectal%20Cancer'>Colorectal Cancer</a></li><li><a href='/medicine.asp?s=Conferences&w=Conference'>Conferences</a></li><li><a href='/medicine.asp?s=Crohn%27s&w=Crohn'>Crohn's</a></li><li><a href='/medicine.asp?s=Cystic%20Fibrosis&w=Fibrosis'>Cystic Fibrosis</a></li><li><a href='/medicine.asp?s=Dengue&w=Dengue'>Dengue</a></li><li><a href='/medicine.asp?s=Dentistry&w=Dentis-Dental'>Dentistry</a></li><li><a href='/medicine.asp?s=Depression&w=Depression'>Depression</a></li><li><a href='/medicine.asp?s=Diabetes&w=Diabetes'>Diabetes</a></li><li><a href='/medicine.asp?s=Drug&w=Drug'>Drug</a></li><li><a href='/medicine.asp?s=Eating%20Disorders&w=Eating-Disorder'>Eating Disorders</a></li><li><a href='/medicine.asp?s=Education&w=Education'>Education</a></li><li><a href='/medicine.asp?s=Epilepsy&w=Epilepsy'>Epilepsy</a></li><li><a href='/medicine.asp?s=Erectile%20Dysfunction&w=Erectile%20Dysfunction'>Erectile Dysfunction</a></li><li><a href='/medicine.asp?s=Eye%20Health/Blindness&w=Eye%20-Blindness'>Eye Health/Blindness</a></li><li><a href='/medicine.asp?s=Fertility&w=Fertility'>Fertility</a></li><li><a href='/medicine.asp?s=Flu/Cold&w=Flu%20-Cold'>Flu/Cold</a></li><li><a href='/medicine.asp?s=GastroIntestinal&w=Gastro'>GastroIntestinal</a></li><li><a href='/medicine.asp?s=Genetics&w=Genetic'>Genetics</a></li><li><a href='/medicine.asp?s=Gout&w=Gout'>Gout</a></li><li><a href='/medicine.asp?s=Headache/Migraine&w=Headache-Migraine'>Headache/Migraine</a></li><li><a href='/medicine.asp?s=Hearing/Deafness&w=Hearing-Deafness'>Hearing/Deafness</a></li><li><a href='/medicine.asp?s=HIV/AIDS&w=HIV/AIDS'>HIV/AIDS</a></li><li><a href='/medicine.asp?s=Huntington%27s%20Disease&w=Huntington'>Huntington's Disease</a></li><li><a href='/medicine.asp?s=Hypertension&w=Hypertension'>Hypertension</a></li><li><a href='/medicine.asp?s=Immune%20System/Vaccines&w=Immune-Vaccine'>Immune System/Vaccines</a></li><li><a href='/medicine.asp?s=Insurance&w=Insurance'>Insurance</a></li><li><a href='/medicine.asp?s=Infectious%20Diseases&w=Infectious'>Infectious Diseases</a></li><li><a href='/medicine.asp?s=Irritable-Bowel%20Syndrome&w=Bowel'>Irritable-Bowel Syndrome</a></li><li><a href='/medicine.asp?s=Internet&w=Internet'>Internet</a></li><li><a href='/medicine.asp?s=Leukemia&w=Leukemia'>Leukemia</a></li><li><a href='/medicine.asp?s=Lifestyle&w=Lifestyle'>Lifestyle</a></li><li><a href='/medicine.asp?s=Liver%20Disease/Hepatitis&w=%20Liver%20-Hepatitis'>Liver Disease/Hepatitis</a></li><li><a href='/medicine.asp?s=Lung%20Cancer&w=Lung%20Cancer'>Lung Cancer</a></li><li><a href='/medicine.asp?s=Lupus&w=Lupus'>Lupus</a></li><li><a href='/medicine.asp?s=Mad%20Cow%20Disease&w=Mad%20Cow'>Mad Cow Disease</a></li><li><a href='/medicine.asp?s=Medical%20Devices&w=Device'>Medical Devices</a></li><li><a href='/medicine.asp?s=Medical%20Students/Training&w=Student-Training'>Medical Students/Training</a></li><li><a href='/medicine.asp?s=Medicare/Medicaid&w=Medicare-Medicaid'>Medicare/Medicaid</a></li><li><a href='/medicine.asp?s=Medico&w=Medico'>Medico</a></li><li><a href='/medicine.asp?s=Men%27s%20health&w=%20Men%20-%20Men%27%27s'>Men's health</a></li><li><a href='/medicine.asp?s=Mental%20Health&w=Mental'>Mental Health</a></li><li><a href='/medicine.asp?s=MRI/Ultrasound&w=MRI-Ultrasound'>MRI/Ultrasound</a></li><li><a href='/medicine.asp?s=MRSA/Drug%20Resistance&w=MRSA-Resistance'>MRSA/Drug Resistance</a></li><li><a href='/medicine.asp?s=Multiple%20Sclerosis&w=Sclerosis'>Multiple Sclerosis</a></li><li><a href='/medicine.asp?s=Muscular%20Dystrophy&w=Muscular%20Dystrophy'>Muscular Dystrophy</a></li><li><a href='/medicine.asp?s=Neurology&w=Neuro'>Neurology</a></li><li><a href='/medicine.asp?s=Nursing&w=Nursing'>Nursing</a></li><li><a href='/medicine.asp?s=Nutrition/Diet&w=Nutrition-Diet'>Nutrition/Diet</a></li><li><a href='/medicine.asp?s=Obesity/Weight%20Loss&w=Obesity-Weight%20Loss'>Obesity/Weight Loss</a></li><li><a href='/medicine.asp?s=Pain/Anesthetics&w=Pain-Anesthetic'>Pain/Anesthetics</a></li><li><a href='/medicine.asp?s=Parkinson%27s%20Disease&w=Parkinson'>Parkinson's Disease</a></li><li><a href='/medicine.asp?s=Pediatrics/Children%27s%20Health&w=Pediatric-Children'>Pediatrics/Children's Health</a></li><li><a href='/medicine.asp?s=Pharma/Biotech%20Industry&w=Pharma-Biotech'>Pharma/Biotech Industry</a></li><li><a href='/medicine.asp?s=Pharmacy/Pharmacists&w=Pharmac'>Pharmacy/Pharmacists</a></li><li><a href='/medicine.asp?s=Pregnancy&w=Pregnancy'>Pregnancy</a></li><li><a href='/medicine.asp?s=Premature&w=Premature'>Premature</a></li><li><a href='/medicine.asp?s=Prostate&w=Prostate'>Prostate</a></li><li><a href='/medicine.asp?s=Psychology/Psychiatry&w=Psych'>Psychology/Psychiatry</a></li><li><a href='/medicine.asp?s=Rehabilitation&w=Rehabilit'>Rehabilitation</a></li><li><a href='/medicine.asp?s=Respiratory/Asthma&w=Respiratory-Asthma'>Respiratory/Asthma</a></li><li><a href='/medicine.asp?s=SARS&w=SARS'>SARS</a></li><li><a href='/medicine.asp?s=Schizophrenia&w=Schizophrenia'>Schizophrenia</a></li><li><a href='/medicine.asp?s=Seniors/Aging&w=Senior-%20Aging'>Seniors/Aging</a></li><li><a href='/medicine.asp?s=Sexual%20Health&w=Sexual'>Sexual Health</a></li><li><a href='/medicine.asp?s=Sleep/Sleep%20Disorders&w=Sleep'>Sleep/Sleep Disorders</a></li><li><a href='/medicine.asp?s=Smoking&w=Smoking'>Smoking</a></li><li><a href='/medicine.asp?s=Statins&w=Statins'>Statins</a></li><li><a href='/medicine.asp?s=Stem%20Cell%20Research&w=Stem%20Cell'>Stem Cell Research</a></li><li><a href='/medicine.asp?s=Stroke&w=Stroke'>Stroke</a></li><li><a href='/medicine.asp?s=Surgery&w=Surgery'>Surgery</a></li><li><a href='/medicine.asp?s=Transplants/Organ%20Donations&w=Transplants-Donation'>Transplants/Organ Donations</a></li><li><a href='/medicine.asp?s=Viruses&w=Virus'>Viruses</a></li><li><a href='/medicine.asp?w=Water-%20Air%20&s=Water%20-%20Air%20Quality'>Water - Air Quality</a></li><li><a href='/medicine.asp?s=Women%27s%20Health&w=Women'>Women's Health</a></li></ul></div></div></div><div id='footer'><table border='0' width='100%'><tr><td align='left'>Copyright © 2003-2012 Bio-Medicine. All rights reserved.<br /><a href='/?q=about_index.html'>ABOUT</a> | <a href='/?q=contact_index.html'>CONTACT US</a> | <a href='/?q=DISCLAIMER_index.html'>DISCLAIMER</a> | <a href='/?q=PrivacyPolicy_index.html'>PRIVACY POLICY</a> | <a href='/?q=TermsAndConditions_index.html'>TERMS AND CONDITIONS</a><br /></td><td align='right'><a href='/'><img src='http://img.bio-medicine.org/images/dbtn.gif' border='0' alt='latest biology and medical news/technology'/></a></td></tr></table></div></div><script type='text/javascript'>document.write('<scr'+'ipt type=\'text/javascript\' src=\'http://js.bio-medicine.org/inc/zjm_cls4.asp?rf='+escape(document.referrer)+'\'></scr'+'ipt>')</script><script src='http://css.bio-medicine.org/images/gdbm.js'></script> <script type="text/javascript"> (function() { var po = document.createElement('script'); po.type = 'text/javascript'; po.async = true; po.src = 'https://apis.google.com/js/plusone.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(po, s); })(); </script> <script src="http://www.google-analytics.com/urchin.js" type="text/javascript"> </script> <script type="text/javascript"> _uacct = "UA-2054987-1"; urchinTracker(); </script> </body></html>